Open access
224
Views
17
CrossRef citations to date
0
Altmetric
Review
CYP2D6 polymorphisms and their influence on risperidone treatment
Apichaya Puangpetch1 Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital
, Natchaya Vanwong1 Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital
, Nopphadol Nuntamool2 Molecular Medicine, Faculty of Science, Mahidol University, Bangkok, Thailand
, Yaowaluck Hongkaew1 Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital
, Monpat Chamnanphon1 Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital
& Chonlaphat Sukasem1 Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi HospitalCorrespondence[email protected]
Pages 131-147
|
Published online: 01 Dec 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.